Oncolines® Technology Platforms for Precision Oncology
Cell-Based Assays to Determine Genetic Drivers and Biological Pathways for Precision Oncology
Oncolines® Cancer Cell Lines, Proliferation Assays and Bioinformatics Analysis
SynergyFinder™ Screen for Synergistic Drug and Therapy Combinations
- Determination of synergy for combination therapy by curve-shift analysis and CI values
- Reference dataset of >180 compounds available
- Hypothesis driven experiments as well as broad screening
Mechanistic Cell Biology, In Vitro Assays to Determine Mechanism of Action
- Flexible assay development and screening,
- Proof of concept studies, determination of mechanism of action
- Testing of a wide range of cancer cells, immune cells and primary patient material in vitro
Efficient, Convenient, Secure Reporting
- Primary data and final reports shared via a secured link
Continuous and High-Throughput Screening
- Turnaround time starts at day of arrival of compounds at Oncolines and ends with transfer of final report and primary data
Oncolines offers a set of complimentary technologies to enable clients to determine the activity, selectivity and mechanism of action of drugs and drug candidates
Available on a fee-for-service basis and collaborations via an integrated precision medicine approach.
It is our mission to bring improved and novel therapies to the right patient population faster.